Page 5,478«..1020..5,4775,4785,4795,480..5,4905,500..»

See inmates play with guns and drugs – Video

Posted: Published on April 5th, 2013

See inmates play with guns and drugs Newly released video from inside a New Orleans jail shows inmates with access to weapons and pills. By: CNN … Continue reading

Posted in Drugs | Comments Off on See inmates play with guns and drugs – Video

Witness – Ida's choice – Video

Posted: Published on April 5th, 2013

Witness - Ida's choice By: AlJazeeraEnglish … Continue reading

Posted in Drugs | Comments Off on Witness – Ida's choice – Video

Inspection missed watered-down cancer drugs

Posted: Published on April 5th, 2013

A regulatory inspection was done while chemotherapy drugs were being watered down by a local pharmacy. The Ontario College of Pharmacists did a routine inspection this past January of Marchese Hospital Solutions, which is located in Mississauga and run by the award-winning pharmacy on James Street North. From Feb. 24, 2012 to March 20, 2013, diluted chemotherapy drugs cyclophosphamide and gemcitabine were given to 1,176 patients in London, Windsor, Peterborough, the Oshawa area and Saint John, N.B. The challenge is that its possible to do a thorough inspection of that practice and that doesnt necessarily mean that you are going to detect an error, said Lori DeCou, spokesperson for the college, speaking generally about pharmacy inspections. The college accredits the provinces 3,500 community pharmacies and inspects them every three to five years. It also regulates the pharmacists who mix the drugs. The college didnt discover the problem with the chemotherapy drugs. Instead, a Peterborough hospital pharmacy worker noticed by chance one of the bags looked too full. I will trust that the college is doing what theyre supposed to be doing, said NDP health critic France Glinas. I hope theyre doing their job. Cancer Care Ontario, the provincial government agency … Continue reading

Posted in Drugs | Comments Off on Inspection missed watered-down cancer drugs

Cancer drugs to stop bioweapons

Posted: Published on April 5th, 2013

Two cancer-combating medicines show potential for protecting U.S. troops and civilians from biological weapon attacks from pathogens like monkeypox. Just this week, monkeypox was involved in some of the eight cases of possible contact with dangerous biological agents at the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick, Md., the Frederick News-Post reported. USAMRIID said last week there were 14 accidents in total involving personnel in full-body protective suits in 2012. Part of the Department of Defense, the Defense Threat Reduction Agency counters weapons of mass destruction from chemical, biological and radiological through to nuclear and high yield explosive threats. The agency is funding St Louis Universitys Mark Buller, who will look at cancer-fighting drugs Gleevec and Tasigna for preventing and treating monkeypox exposure. The Monkeypox threat Monkeypox is similar to smallpox. First found in monkeys, the disease was reported in humans for the first time in 1970, but the first U.S. outbreak didnt occur until ten years ago. In that outbreak (which is believed to have been unintentional), Americans became sick from contact with infected prairie dogs. The disease can also spread from person to person through face-to-face contact or by touching an infected persons body … Continue reading

Posted in Drugs | Comments Off on Cancer drugs to stop bioweapons

Cramer: Investing in Future of Cancer Drugs

Posted: Published on April 5th, 2013

Onyx Pharmaceuticals Jim Cramer said that Onyx is known for the drug Nexavar, which is used to treat liver and kidney cancer. "It is a remarkable drug because these cancers have stymied doctors for years," he said. In addition to the drug's current success, it may have other uses too. "It's also being studied for thyroid cancer and breast cancer," said Cramer. To provide perspective on the total profit potential, it's already doing a billion dollars in sales globally, Cramer said. "And in September the FDA approved Stivarga, a colorectal cancer drug that Onyx developed in partnership with Bayerthis could be a billion dollar drug, and Onyx gets a 20% royalty," said Cramer. Also the Mad Money host said to keep an eye on an Onyx treatment for multiple myeloma. "The FDA approved it last July and it could potentially be worth $2.3 billion in sales by 2018," he said. In addition, Cramer said they're developing a breast cancer drug with Pfizer that's in phase 3 trials. "This could ultimately generate peak sales of $5 billion, and Onyx gets an 8% cut, which comes to $400 million." Call Cramer: 1-800-743-CNBC Questions for Cramer? madmoney@cnbc.com Questions, comments, suggestions for the "Mad … Continue reading

Posted in Drugs | Comments Off on Cramer: Investing in Future of Cancer Drugs

Signature Patient Advocates Commercial – Video

Posted: Published on April 5th, 2013

Signature Patient Advocates Commercial This Is a ad created by Star words Media And Marketing LLC2013 http://www.signaturepatientadvocates.com/. By: roland mitchell … Continue reading

Posted in Pharmacy | Comments Off on Signature Patient Advocates Commercial – Video

Talyst at the Acute Care Pharmacy – Video

Posted: Published on April 5th, 2013

Talyst at the Acute Care Pharmacy An overview of what Talyst does for Hospital Pharmacies. By: Talyst Corporate … Continue reading

Posted in Pharmacy | Comments Off on Talyst at the Acute Care Pharmacy – Video

Heart Pharmacy The Story (HD) – Video

Posted: Published on April 5th, 2013

Heart Pharmacy The Story (HD) Albums: "Drive" (2012) - itunes.apple.com/ie/album/drive/id533341750 "Natural Selection" (2008) - itunes.apple.com/ie/album/natural-selection/id289084820 htt... By: Ali Sarijlou … Continue reading

Posted in Pharmacy | Comments Off on Heart Pharmacy The Story (HD) – Video

Sarepta Therapeutics Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb …

Posted: Published on April 5th, 2013

CAMBRIDGE, MA--(Marketwired - Apr 5, 2013) - Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced updated data from Study 202, a Phase IIb open-label extension study of eteplirsen in patients with Duchenne muscular dystrophy (DMD). Results at 74 weeks showed a continued stabilization of walking ability in eteplirsen-treated patients evaluable on the 6-minute walk test (6MWT). As previously reported, Study 202 met its primary endpoint of increased novel dystrophin as assessed by muscle biopsy at week 48 and is now in the long-term extension phase in which patients continue to be followed for safety and clinical outcomes. Eteplirsen is Sarepta's lead exon-skipping compound in development for the treatment of patients with DMD who have a genotype amenable to skipping of exon 51. After 74 weeks, patients in the 30 mg/kg and 50 mg/kg dose cohorts who were able to perform the 6MWT (modified Intent-to-Treat or mITT population; n=6) showed a statistically significant treatment benefit of 65.2 meters (p 0.004) when compared to the placebo/delayed-treatment cohort (n=4). The eteplirsen-treated patients in the mITT population demonstrated less than a 5 percent decline (13.4 meters) from baseline in walking ability. After experiencing a substantial decline earlier in the … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Sarepta Therapeutics Announces Eteplirsen Demonstrates Sustained Benefit on Walking Test Through 74 Weeks in Phase IIb …

Art for a Cure tonight at Provident Bank

Posted: Published on April 5th, 2013

Today's most viewed articles EXETER Today, April 5 from 6 to 8 p.m., at The Provident Bank in Exeter (95 Portsmouth Ave.), eighth-grader Rebecca Gowing and art teacher Crystal Buswell will host an art show, reception and silent auction to raise awareness of Duchenne Muscular Dystrophy. Duchenne Muscular Dystrophy is a little known and often misunderstood genetic disorder, and tonight's event looks to raise funds on behalf of Parent Project Muscular Dystrophy (PPMD). Art for a Cure art show and silent auction When: From 6-8 p.m., Friday, April 5 Where: The Provident Bank, 95 Portsmouth Ave., Exeter More: facebook.com/ArtToCureDMD There are at least two young men third-grader Cameron Yurik of Brentwood and fifth-grader Lucas Currier of Newfields in our community with this progressive muscle disorder. PPMD is a national nonprofit organization started in 1994 by parents of young men diagnosed with Duchenne. Gowing is actively involved with PPMD and hopes to inspire the Seacoast community to come out, have fun, and purchase beautiful artwork in support of PPMD. The art show will feature nature-themed two-dimensional artwork by both students and professional artists. Students in the third and fifth grade classes of the young men who have Duchenne will be creating … Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Art for a Cure tonight at Provident Bank

Page 5,478«..1020..5,4775,4785,4795,480..5,4905,500..»